Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer
Comparison of Ivor Lewis and Tri-incision Approaches in Performing Minimally
Sponsor: National Taiwan University Hospital
This NA trial investigates Cancer of Esophagus and Esophageal Neoplasms and is currently ongoing. National Taiwan University Hospital leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Mar 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Taiwan University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .